Murali Yallapu Receives $439,818 Grant to Continue Drug Development for Aggressive and Late Stage Breast Cancer
|
Breast cancer is the most common form of cancer for women in both developed and underdeveloped countries. With survival rates varying worldwide, it is imperative that novel research be undertaken to combat this global health concern. Murali Yallapu, PhD, assistant professor in the College of Pharmacy at the University of Tennessee Health Science Center, has… Read More